Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Shares Outstanding (Weighted Average) (2016 - 2026)

Cytosorbents filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $62.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 14.32% to $62.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.2 million, a 14.32% increase, with the full-year FY2025 number at $62.2 million, up 14.32% from a year prior.
  • Shares Outstanding (Weighted Average) hit $62.2 million in Q4 2025 for Cytosorbents, roughly flat from $62.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $62.2 million in Q4 2025 to a low of $2.7 million in Q4 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $43.6 million (2022), compared with a mean of $44.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 144042.64% in 2021 and later crashed 93.79% in 2023.
  • Cytosorbents' Shares Outstanding (Weighted Average) stood at $43.4 million in 2021, then increased by 0.49% to $43.6 million in 2022, then crashed by 93.79% to $2.7 million in 2023, then surged by 1911.21% to $54.4 million in 2024, then grew by 14.32% to $62.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $62.2 million (Q4 2025), $62.0 million (Q3 2025), and $61.7 million (Q2 2025) per Business Quant data.